bitBiome, Inc.: bitBiome and Kaken Pharmaceuticals sign join

-The joint research will use bitBiome's drug discovery platform technology to search for drug candidate substances- TOKYO, March 29, 2023 /PRNewswire/ -- bitBiome, Inc. (Head office: Shinjuku-ku

Related Keywords

Tokyo , Japan , Kaken , Niedersachsen , Germany , Bunkyo Ku , Shinjuku Ku , Hiroyuki Horiuchi , Ryuji Suzuki , Kaken Pharmaceuticals Head , Ubiome Inc , , Kaken Pharmaceuticals , Long Term Business Plan , Chief Executive Officer , Diese Gold Aktie , Sichern Sie , Bitbiome , Aken , Pharmaceuticals , Sign , Joint , Research , Agreement , Discovery , Drugs , Nfectious , Diseases ,